Effect of long-acting polyethylene glycol recombinant human growth hormone dosages in pediatric practice: A pooled analysis of two phase IV randomized controlled trials

According to the intention-to-treat principle, all randomized participants who used at least one dose of PEG-rhGH with efficacy data constituted the full-analysis set (FAS). [...]after 26 weeks of treatment, bone age assessment revealed no statistically significant differences between the two groups...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical journal 2024-09, Vol.137 (17), p.2125-2127
Hauptverfasser: Hou, Ling, Chen, Xuefeng, Du, Hongwei, Zhang, Jianping, Cheng, Xinran, Pan, Jiayan, Pan, Hui, Liao, Wei, Luo, Xiaoping, Fu, Junfen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to the intention-to-treat principle, all randomized participants who used at least one dose of PEG-rhGH with efficacy data constituted the full-analysis set (FAS). [...]after 26 weeks of treatment, bone age assessment revealed no statistically significant differences between the two groups. [...]PEG-rhGH proved efficacy and safety in children with GHD. Junfen Fu, Department of Endocrinology, Children’s Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China E-Mail: fjf68@zju.edu.cn; Xiaoping Luo, Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China E-Mail: xpluo@tjh.tjmu.edu.cn How to cite this article:
ISSN:0366-6999
2542-5641
2542-5641
DOI:10.1097/CM9.0000000000002954